Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TP53 mutation and survival in aggressive B cell lymphoma.
Zenz T, Kreuz M, Fuge M, Klapper W, Horn H, Staiger AM, Winter D, Helfrich H, Huellein J, Hansmann ML, Stein H, Feller A, Möller P, Schmitz N, Trümper L, Loeffler M, Siebert R, Rosenwald A, Ott G, Pfreundschuh M, Stilgenbauer S; German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Zenz T, et al. Among authors: stilgenbauer s. Int J Cancer. 2017 Oct 1;141(7):1381-1388. doi: 10.1002/ijc.30838. Epub 2017 Jun 26. Int J Cancer. 2017. PMID: 28614910 Clinical Trial.
Pathogenic complexity of gastric B-cell lymphoma.
Barth TF, Bentz M, Leithäuser F, Stilgenbauer S, Siebert R, Schlotter M, Schlenk RF, Döhner H, Möller P. Barth TF, et al. Among authors: stilgenbauer s. Blood. 2002 Aug 1;100(3):1095-6; author reply 1096-7. doi: 10.1182/blood-2002-02-0423. Blood. 2002. PMID: 12130478 Free article. No abstract available.
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome.
Kienle D, Kröber A, Katzenberger T, Ott G, Leupolt E, Barth TF, Möller P, Benner A, Habermann A, Müller-Hermelink HK, Bentz M, Lichter P, Dōhner H, Stilgenbauer S. Kienle D, et al. Among authors: stilgenbauer s. Blood. 2003 Oct 15;102(8):3003-9. doi: 10.1182/blood-2003-05-1383. Epub 2003 Jul 3. Blood. 2003. PMID: 12842981 Free article.
Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.
Kohlhammer H, Schwaenen C, Wessendorf S, Holzmann K, Kestler HA, Kienle D, Barth TF, Möller P, Ott G, Kalla J, Radlwimmer B, Pscherer A, Stilgenbauer S, Döhner H, Lichter P, Bentz M. Kohlhammer H, et al. Among authors: stilgenbauer s. Blood. 2004 Aug 1;104(3):795-801. doi: 10.1182/blood-2003-12-4175. Epub 2004 Apr 13. Blood. 2004. PMID: 15090459 Free article.
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
Ringhoffer M, Blumstein N, Neumaier B, Glatting G, von Harsdorf S, Buchmann I, Wiesneth M, Kotzerke J, Zenz T, Buck AK, Schauwecker P, Stilgenbauer S, Döhner H, Reske SN, Bunjes D. Ringhoffer M, et al. Among authors: stilgenbauer s. Br J Haematol. 2005 Aug;130(4):604-13. doi: 10.1111/j.1365-2141.2005.05663.x. Br J Haematol. 2005. PMID: 16098076 Free article. Clinical Trial.
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
Zenz T, Schlenk RF, Glatting G, Neumaier B, Blumstein N, Buchmann I, von Harsdorf S, Ringhoffer M, Wiesneth M, Keller F, Kotzerke J, Röttinger E, Stilgenbauer S, Döhner H, Reske SN, Bunjes D. Zenz T, et al. Among authors: stilgenbauer s. J Nucl Med. 2006 Feb;47(2):278-86. J Nucl Med. 2006. PMID: 16455634 Free article. Clinical Trial.
Molecular imaging of proliferation in malignant lymphoma.
Buck AK, Bommer M, Stilgenbauer S, Juweid M, Glatting G, Schirrmeister H, Mattfeldt T, Tepsic D, Bunjes D, Mottaghy FM, Krause BJ, Neumaier B, Döhner H, Möller P, Reske SN. Buck AK, et al. Among authors: stilgenbauer s. Cancer Res. 2006 Nov 15;66(22):11055-61. doi: 10.1158/0008-5472.CAN-06-1955. Cancer Res. 2006. PMID: 17108145
Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse.
Ringhoffer M, Harsdorf Sv, Schmitt M, Wiesneth M, Zenz T, Stilgenbauer S, Greiner J, Döhner K, Marx M, Döhner H, Bunjes D. Ringhoffer M, et al. Among authors: stilgenbauer s. Br J Haematol. 2007 Jan;136(1):127-30. doi: 10.1111/j.1365-2141.2006.06404.x. Br J Haematol. 2007. PMID: 17222200 Free article. Clinical Trial.
584 results